Umberto Veronesi’s legacy
With the death of Umberto Veronesi last November, the cancer world has lost one of its great leaders, and we at the European School of Oncology have lost our inspiration and founder. In this issue [more]
Number 76
With the death of Umberto Veronesi last November, the cancer world has lost one of its great leaders, and we at the European School of Oncology have lost our inspiration and founder. In this issue we remember his achievements as a... [ more ]
From the maximum tolerable to the minimum effective – Remembering Umberto Veronesi’s contribution to cancer care
Umberto Veronesi passed away on the 8th of November 2016, at the end of a career dedicated to fighting cancer. During his long and productive life he made significant contributions to improving cancer care and [more]
Population screening in the age of personalised medicine
The risk of developing breast cancer varies widely from woman to woman in ways we are increasingly able to define. Marc Beishon asks: Is it time to move to population screening for risk, and tailor mammography schedules – [more]
Why is the end-of-life experience still not improving?
Efforts to improve symptom control near the end of life have received more attention in recent years, but the impact is often frustratingly small. Simon Crompton asks where we are going wrong. Seven years ago, [more]
George Pentheroudakis: blue-sky thinking in Greece
The head of Medical Oncology at Ioannina University Hospital not only oversees ESMO’s prolific output of clinical guidelines, but also helps ensure that they can be sustainably delivered in his own country, where hospital budgets [more]
Systematic reviews – your key to evidence-based medicine
Evidence-based medicine is the cornerstone of medical practice, and yet clinicians are rarely offered training in the tricky business of finding, evaluating and making sense of the evidence they need. Anna Rouillard reports on an [more]
No time! How staff shortages are hitting patient care
The European Commission has issued a warning about a 1 million projected shortfall in Europe’s clinical workforce by 2020 – with nursing shortages accounting for more than half the total. Marc Beishon reports on the [more]
The role of immunotherapy in treating solid cancers
Engaging the body’s own immune system in controlling cancer has long been an aspiration for cancer researchers and clinicians. This overview looks at progress towards that goal, and how it is changing the paradigm of [more]
If accessing relevant evidence is the question, are medical journals still the answer?
With social media platforms, search algorithms and online research tools designed to let people upload, share, find and comment on information in real time, Sophie Fessl asks: why are we still reliant on a 350-year-old [more]
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
Combining the complementary approaches of HPV vaccination and screening could accelerate declines in the burden of cervical cancer argue Xavier Bosch and colleagues. They are proposing the HPV-FASTER protocol as a way to achieve it. [more]
Philip Poortmans – ECCO President-elect
As ECCO’s new President-elect, Philip Poortmans is the first person to have a full democratic mandate from across all ECCO’s 24 member societies which, between them, represent the full range of healthcare professionals involved in [more]